Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06068348 · ClinicalTrials.gov registry record
Liquid Biopsy Collection Study
A clinical trial of Circulating Tumor Cells and Chaperonin-Containing TCP-1, sponsored by University of Central Florida.
- Active
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT06068348: Active study of Circulating Tumor Cells and Chaperonin-Containing TCP-1, sponsored by University of Central Florida.
NCT06068348 is a study of Circulating Tumor Cells and Chaperonin-Containing TCP-1 that is active but no longer recruiting, run by University of Central Florida. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06068348, a study of Circulating Tumor Cells and Chaperonin-Containing TCP-1, is active but no longer recruiting, sponsored by University of Central Florida.
- ACTIVE NOT RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop a liquid biopsy approach for detection of circulating tumor cells (CTC) that could be used in place of the more invasive and potentially risky methods of tissue biopsy. The aims of the project are: (a) determine whether the Chaperonin-Containing TCP-1 (CCT) chaperonin can used to identify rare cancer cells in blood, and (b) establish whether the cancer cells detected using the CCT chaperonin for identification have invasive or metastatic potential.
Conditions Studied
Study Locations (1)
Florida
- University of Central Florida - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-10-07 |
| Est. Completion | 2025-10 |
What the registry record for NCT06068348 still lists
NCT06068348 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 4 conditions, with Circulating Tumor Cells appearing as the primary indexed condition, and to 0 interventions.
NCT06068348 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06068348 about?
NCT06068348 is a clinical study titled "Liquid Biopsy Collection Study". The purpose of this study is to develop a liquid biopsy approach for detection of circulating tumor cells (CTC) that could be used in place of the more invasive and potentially risky methods of tissue biopsy. The aims of the project are: (a) determine whether the Chaperonin-Containing TCP-1 (CCT) ch...
What is the current status of trial NCT06068348?
This trial is currently active not recruiting. The enrollment target is 60 participants. The study started on 2021-10-07. Estimated completion is 2025-10.
What conditions does trial NCT06068348 study?
This clinical trial studies the following conditions: Circulating Tumor Cells, Chaperonin-Containing TCP-1, CCT, CTC.
Who is sponsoring clinical trial NCT06068348?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06068348 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Circulating Tumor Cells
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI